Etanercept: a review of its use in rheumatoid arthritis (Q33684274)

28 July 2017

1 reference

title

Etanercept: a review of its use in rheumatoid arthritis (English)

1 reference

28 July 2017

1 reference

B Jarvis

1

1 reference

PubMed ID

10400407

28 July 2017

D Faulds

series ordinal

2

1 reference

28 July 2017

1 June 1999

1 reference

28 July 2017

1 reference

28 July 2017

57

1 reference

28 July 2017

6

1 reference

28 July 2017

945-966

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199957060-00014

28 July 2017

0 references

cites work

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

12 December 2020

Joint destruction in rheumatoid arthritis: biological bases.

1 reference

12 December 2020

Regulation of autoimmunity by proinflammatory cytokines

1 reference

12 December 2020

Cachectin/tumour necrosis factor-alpha in the circulation of patients with rheumatic disease

1 reference

12 December 2020

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

12 December 2020

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Tumor necrosis factor receptor superfamily members and their ligands

1 reference

12 December 2020

Preliminary definition of improvement in juvenile arthritis

1 reference

12 December 2020

A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference.

1 reference

12 December 2020

1 reference

12 December 2020

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

12 December 2020

Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitor

1 reference

12 December 2020

Second-line drug therapy for rheumatoid arthritis

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

1 reference

12 December 2020

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

12 December 2020

The role of cytokines in gestation.

1 reference

12 December 2020

Are slow-acting anti-rheumatic drugs monitored too often? An audit of current clinical practice

1 reference

12 December 2020

Recombinant human tumor necrosis factor receptor Fc fusion protein therapy in kidney transplant recipients undergoing OKT3 induction therapy

1 reference

12 December 2020

Adverse drug reactions of DMARDs and DC-ARTs in rheumatoid arthritis.

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Anticytokine therapy in rheumatoid arthritis

1 reference

12 December 2020

Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

12 December 2020

Cytokines in rheumatoid arthritis. Localization in arthritic joint tissue and regulation in vitro.

1 reference

12 December 2020

Joint erosions and patients with early rheumatoid arthritis

1 reference

12 December 2020

The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases

1 reference

12 December 2020

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids

1 reference

12 December 2020

Structure of tumour necrosis factor

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Disease-modifying anti-rheumatic drugs. Cyclosporin

1 reference

12 December 2020

How and when should combination therapy be used? The role of an anchor drug

1 reference

12 December 2020

Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).

1 reference

12 December 2020

The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates.

1 reference

12 December 2020

Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.

1 reference

12 December 2020

Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha

1 reference

12 December 2020

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

1 reference

12 December 2020

Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

Glucocorticosteroids in rheumatoid arthritis: lessons for the future

1 reference

12 December 2020

The use of biologics in the treatment of rheumatoid arthritis (RA)--the good news and the bad news

1 reference

12 December 2020

The effect of recombinant tumor necrosis factor-alpha on superoxide and metalloproteinase production by synovial cells and chondrocytes

1 reference

12 December 2020

Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor

1 reference

12 December 2020

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

12 December 2020

Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

12 December 2020

Biological effects and fate of a soluble, dimeric, 80-kDa tumor necrosis factor receptor in renal transplant recipients who receive OKT3 therapy

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

Tumor necrosis factor-alpha in the female reproductive tract.

1 reference

12 December 2020

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

12 December 2020

Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?

1 reference

12 December 2020

Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts

1 reference

12 December 2020

Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.

1 reference

12 December 2020

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

12 December 2020

Sulphasalazine in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Injectable gold compounds: an overview

1 reference

12 December 2020

Clinical guidelines for management

1 reference

12 December 2020

Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production b

1 reference

12 December 2020

1 reference

12 December 2020

Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis

1 reference

12 December 2020

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.

1 reference

12 December 2020

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists

1 reference

12 December 2020

Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein

1 reference

12 December 2020

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome

1 reference

12 December 2020

A human inhibitor of tumor necrosis factor alpha

1 reference

12 December 2020

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

12 December 2020

Long-term outcomes in rheumatoid arthritis

1 reference

12 December 2020

Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis

1 reference

12 December 2020

Pharmacokinetic parameters and biodistribution of soluble cytokine receptors

1 reference

12 December 2020

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy

1 reference

12 December 2020

Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice

1 reference

12 December 2020

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis

1 reference

12 December 2020

Rheumatoid arthritis: treat now, not later!

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures

1 reference

12 December 2020

The tumor necrosis factor ligand and receptor families.

1 reference

12 December 2020

Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis

1 reference

12 December 2020

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

12 December 2020

p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts

1 reference

12 December 2020

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

1 reference

12 December 2020

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells

1 reference

12 December 2020

Treatment of rheumatoid arthritis

1 reference

12 December 2020

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein

1 reference

12 December 2020

The burden of rheumatoid arthritis: facts and figures.

1 reference

12 December 2020

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

1 reference

12 December 2020

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

12 December 2020

Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset

1 reference

12 December 2020

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1 reference

12 December 2020

Receptor-mediated label-transfer assay (RELAY): a novel method for the detection of plasma tumor necrosis factor at attomolar concentrations.

1 reference

12 December 2020

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum

1 reference

12 December 2020

Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice

1 reference

12 December 2020

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

12 December 2020

Differential effects of IL-1 and TNF alpha on the expression of stromelysin, collagenase and their natural inhibitor, TIMP, in rheumatoid human synovial fibroblasts

1 reference

12 December 2020

Taming TNF: strategies to restrain this proinflammatory cytokine

1 reference

12 December 2020

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

12 December 2020

Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience

1 reference

12 December 2020

Science, medicine, and the future. Treatment of rheumatoid arthritis

1 reference

12 December 2020

Antimalarial drugs in the treatment of rheumatological diseases

1 reference

12 December 2020

The cost of rheumatoid arthritis

1 reference

12 December 2020

10.2165/00003495-199957060-00014

Identifiers

DOI

1 reference

PubMed ID

10400407

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10400407